About

Erik P. Castle is a pioneering urologic surgeon and researcher whose work has fundamentally shaped the adoption and standardization of robotic surgery in urology. Based at Mayo Clinic, Castle has dedicated his career to advancing minimally invasive surgical techniques for bladder cancer, prostate cancer, and reconstructive urological procedures. He is perhaps best known as a principal investigator on the landmark RAZOR trial, a randomized phase 3 study demonstrating the non-inferiority of robot-assisted radical cystectomy compared to open surgery, which has accumulated over 760 citations and directly influenced global surgical practice. His contributions extend beyond clinical outcomes: his early work on robotic pyeloplasty in children and concomitant stone management helped establish robotic techniques in pediatric urology. Castle also played a critical role in shaping how surgeons are trained and credentialed in robotic surgery, co-authoring widely cited guidelines for the Society of Urologic Robotic Surgeons. Through the International Robotic Cystectomy Consortium, he helped define learning curves and best practices for robotic cystectomy across institutions. With thousands of citations collectively, his research has been indispensable to the safe, evidence-based expansion of robotic urology worldwide.

Research Focus

Key Achievements

35
H-Index
86
Papers
4,802
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
760 citations · 2018
📈 Most Prolific Year: 2011 (12 Papers)
🤝 Key Collaborators: 304
🏛 Institutions: WinnMed, Mayo Clinic in Arizona, Mayo Clinic, Mayo Clinic Hospital, Tulane University, Mayo Clinic in Florida

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 42 days ago